Salute e Benessere

Biotech Entrepreneur Veronica Gambillara Fonck Appointed Chair of MinervaX

Per Fischer, Chief Executive Officer of MinervaX, said: "Veronica has been a key member of our board since October 2022 and her extensive vaccine development experience has been invaluable in the progress of our novel, prophylactic vaccine candidate against GBS. Veronica in her new role as Chair will oversee the next important phase of company development as we prepare for Phase III studies with our maternal GBS vaccine. I would like to thank Gerd for his valuable contributions to the…
PR Newswire
14/11/2024

Pneumonia Vaccine Market Poised for Significant Expansion: Projected to Achieve…

Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=209931 Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=209931 202 - Pages 126 – Tables 37 – Figures Scope Of The Report Pneumonia Vaccine Market Overview Geographic Dominance : The Pneumonia Vaccine Market exhibits distinct geographic dominance, with varying growth patterns across different regions.North AmericaandEuropeare currently...
PR Newswire
14/11/2024

Healthcare IT Market to Hit USD 834.35 Billion by 2029 with 14.7% CAGR |…

Browse in-depth TOC on "Healthcare IT Market" Browse in-depth TOC on "Healthcare IT Market" 320 - Tables 50 - Figures 420 - Pages Based on Components,the Healthcare IT market is segmented into services, software, and hardware. The largest share of the healthcare IT market was held by the services segment in 2023. The growth can be attributed to the following factors: healthcare organizations rely heavily on service providers for consulting, storage, implementation,...
PR Newswire
14/11/2024

PEGylated Proteins Market Set to Reach USD 19.1 Billion by 2031, Driven by…

Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=222584 Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=222584 202 - Pages 126 – Tables 37 – Figures Scope Of The Report PEGylated Proteins Market Overview Geographic Dominance : North Americaholds a dominant position in the PEGylated Proteins Market, driven by a well-established pharmaceutical and biotechnology sector, advanced healthcare...
PR Newswire
14/11/2024

Protein Expression Market to Hit USD 4.82 Billion by 2029 with 7.1% CAGR |…

Browse in-depth TOC on "Protein Expression Market" Browse in-depth TOC on "Protein Expression Market" 632 - Tables 71 - Figures 470 - Pages Based on system type,the protein expression market is segmented into mammalian cell expression systems, prokaryotic expression systems, cell-free expression systems, yeast expression systems, insect cell expression systems, and algal-based expression systems. In 2023, the mammalian cell expression systems segment held the largest share...
PR Newswire
14/11/2024

Luxury Leaders Gather at the Neiman Marcus Awards to Honor Leonard A. Lauder

"Honoring Leonard Lauder tonight is especially meaningful. He transformed a brand created by his mother into a global icon and carries forward a legacy rooted in deep customer connection—a philosophy driving The Estée Lauder Companies' remarkable global business," said Geoffroy van Raemdonck, CEO, Neiman Marcus Group. "His vision has elevated luxury standards, reshaping industry possibilities and inspiring both innovation and elegance. We're excited to partner with ELC's brands to…
PR Newswire
14/11/2024

Lexogen launches Streamlined, Large-scale RNA-Seq Service for Blood Samples

At Lexogen NGS Services, the proprietary technologies are fully integrated into customizable, end-to-end Blood RNA-Seq Service workflows, available with RNA extraction from blood collection tubes and tailored data analysis. Blood-specific custom workflows, e.g., for efficient detection of isoforms and splice variants, are implemented. The newhigh-throughput RNA-Seq workflow for blood represents the most streamlined approach for blood transcriptomics screening and is now exclusively available as…
PR Newswire
14/11/2024

Coronado Research Limited announce the appointment of Alexander McCormick as…

Alexander commented, "I have collaborated with Andrew for many years within clinical research to drive innovation on multiple occasions. When Andrew laid out the mission and objectives of Coronado Research, I was excited by the opportunity to join such a strong leadership team. Our objective is to revolutionize the clinical research process and challenge the status quo of how we bring drugs to market today. I am very much looking forward to working with the team to bring positive change to…
PR Newswire
14/11/2024

Kerecis included on the list of covered products for Diabetic Foot Ulcers in the…

On 14 November 2024, the U.S. Centers for Medicare & Medicaid Services (CMS) issued a final Local Coverage Determination (LCD) 1policy regarding skin substitute grafts/cellular and tissue-based products for the treatment of Diabetic Foot Ulcers (DFUs) and venous leg ulcers (VLUs) in the Medicare population.The final LCD policy confirms the introduction of a technical qualification and a clinical efficacy qualification, proposed in a draft LCD policy 2earlier this year. The final...
Nasdaq GlobeNewswire
14/11/2024

IM Cannabis Reports Third Quarter Financial Results

Q3 2024 Financial Highlights Q3 2024 Financial Highlights Management Commentary "While the 66% growth we delivered inGermany, to reach$5.8Mthis quarter is a highlight, we spent the quarter focused on building a solid foundation for 2025," said Oren Shuster, Chief Executive Officer of IMC. "Our goal was to build a strong, consistent supply chain, along with a laser focus on how to improve the efficiency and accuracy of how we use our resources. I believe that the foundation...
PR Newswire
14/11/2024

WuXi AppTec's Couvet Site Receives EcoVadis 2024 Silver Medal Rating

As a state-of-the-art pharmaceutical manufacturing facility, the Couvet site plays a vital role in WuXi AppTec's CRDMO business model by providing both clinical and commercial scale manufacturing capabilities for oral solid dosage forms. The facility was designed with industry-leading energy efficiency and environmental standards and was built to accommodate future sustainable growth. As a state-of-the-art pharmaceutical manufacturing facility, the Couvet site plays a vital role in WuXi...
PR Newswire
14/11/2024

Biotech Companies' Q3 Updates: Promising Cancer Treatments on the Horizon

The article continued: As reported by The Guardian, a new study is raising hopes of treating aggressive cancers by zapping rogue DNA that helps tumors thrive and become resistant to chemotherapy. Showing the shifting market, researchers at Statista recently released a report showing the Top 5 Oncology Products Worldwide by Market Share in 2017 and 2024. The article continued:As reportedbyThe Guardian,a new study is raising hopes of treating aggressive cancers by zapping rogue DNA that...
PR Newswire
14/11/2024

Tilray Medical Launches its First Commercial “Grown in Germany” Medical Cannabis…

On July 15, 2024, Tilray Medical was the first to receive a new cannabis cultivation license issued under MedCanG. This license allows Aphria RX to cultivate and manufacture a broad range of commercially available medical cannabis in Germany. The strains to be grown at this indoor facility have been carefully selected from top performing varieties popular with patients across Canada.Tilray's Chief Strategy Officer and Head of International, Denise Faltischek, said, "We are excited to...
Nasdaq GlobeNewswire
14/11/2024

AC Immune Reports Positive Interim Results from Phase 2 Trial of ACI-7104.056…

AC Immune Reports Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson's DiseaseActive immunotherapy with ACI-7104.056 induces high anti-a-synuclein antibody levels on average 16-fold higher than placebo after 3 immunizations100% of patients receiving ACI-7104.056 responded against the target antigenACI-7104.056 is well tolerated with no clinically relevant safety issues reported to dateLausanne, Switzerland, November 14, 2024– AC...
Nasdaq GlobeNewswire
14/11/2024

Bridge to Life Ltd. Achieves Global Milestone Using Hypothermic Oxygenated…

"We are proud to be the liver transplantation center that has reached this milestone for Bridge to Life," commented Russell Bolton, Head of Liver Services, UHB Liver Services Unit. "As one of the largest transplantation centers in the UK, providing a comprehensive range of hepatology (liver medicine), liver surgery, and liver transplantation services to our patients, UHB has been at the forefront of adopting new technologies that can make more livers available to patients in…
PR Newswire
14/11/2024

Neuraxpharm reports another year of sustained growth and international expansion

International expansion across Europe and beyond International expansion acrossEuropeand beyond Since its creation over 35-years ago, and its subsequent acquisition by Permira in 2020, Neuraxpharm has pursued its objective of becoming the partner of choice in CNS. Building on this heritage, and following its rebranding in 2018, Neuraxpharm has established itself as a leading European specialty pharma company focused on the treatment of psychiatric and neurological CNS disorders...
PR Newswire
14/11/2024

Suvoda Awarded US Patent for its eCOA Software Architecture

The patent demonstrates the power of Suvoda eCOA: expedited questionnaire creation, translation, localization, and deployment so clinical trial sponsors can launch their studies more efficiently. While eCOA is traditionally a bottleneck in clinical trial implementation, Suvoda eCOA and its SQDL tool enable sponsors to deliver high quality questionnaires in a matter of hours, instead of days. The patent demonstratesthe power of Suvoda eCOA: expedited questionnaire creation, translation,...
PR Newswire
14/11/2024

Sanofi Partners With Beano & Breakthrough T1D UK to Raise Awareness of…

T1D is an autoimmune, complex, and lifelong condition – and it can happen to anyone at any age even without family history.[1] It can be a challenging disease with lifelong clinical, economic, and emotional unmet needs for patients and families. In the UK, there is a growing prevalence where approximately 400,000 people are living with the disease, including about 36,000 people 19 years of age and younger.[2],[3] It is known that T1D is not caused by diet or lifestyle, however, currently the…
PR Newswire
14/11/2024

Register Now for HOTEL & SHOP PLUS 2025 at Shanghai

Products and Benefits from HSP 2025 Products and Benefits from HSP 2025 The exhibition will showcase a variety of high-end, eco-friendly materials and products across categories like construction, design, smart hotels, lighting, retail, smart office, landscaping, cleaning and operation and maintenance, etc. It will also feature creative designs and advanced intelligent systems. Hall E features construction materials like architectural decoration, ceramics, and outdoor furniture,...
PR Newswire
14/11/2024

Xeltis announces FDA Breakthrough Device Designation for aXessTM and first…

Eliane Schutte, Chief Executive Officer, Xeltis commented:"We are in a transformative period for Xeltis, and this designation from the FDA is great recognition of the potential importance of our highly novel technology. We are also extremely proud that the first patient in our US pivotal trial has now been treated, and this clinical achievement provides us with significant momentum as we advance towards commercialization." Eliane Schutte, Chief Executive Officer, Xeltis commented…
PR Newswire
14/11/2024

Mallinckrodt announces the 2024 Winner of the Extracorporeal Immunomodulation…

The EIA-winning project was submitted by Dr Andrea Varkonyi, of the South-Pest Central Hospital, National Institute of Hematology and Infectiology's Department of Hematology and Stem Cell Transplantation, in Budapest, Hungary. Her team will carry out a retrospective and prospective study, comparing ruxolitinib alone to ruxolitinib combined with ECP therapy in the treatment of acute and chronic GvHD. They will also evaluate the impact of ECP on the development of transplant-associated thrombotic…
PR Newswire
14/11/2024

Implantica submits FDA PMA application Clinical Module 2 for RefluxStop™ for…

Dr. Peter Forsell, CEO of Implantica, says, "The incredible enthusiasm for RefluxStop™ among top surgeons at the recent annual American Foregut Society and European Foregut Society meetings is a testimony to the immense demand for innovation in the surgical treatment of GERD. This support is growing fast, fueled by RefluxStop's excellent clinical outcomes, both in our pivotal 5-year study but also supported by multiple centers around Europe presenting their equally excellent results. This…
PR Newswire
14/11/2024

City of Savonlinna has chosen Aino's SaaS platform

Yet another Finnish public organization, the City of Savonlinna, has chosen Aino's SaaS platform. As part of a strong initiative to build a more sustainable work environment, to manage staffing needs and secure the competence supply, to be a more attractive employer. The agreement includes a total of 1100 employees and the Aino SaaS platform is in production use from the fourth quarter of 2024. “As a public employer we should always aim for a holistic and systematic approach to our...
Nasdaq GlobeNewswire
14/11/2024

Casino Group: 2028 Strategic Plan

Casino Group: a strategic plan to achievethe best of brands in convenience retailing Paris, 14 November 2024 A strategic plan named "Renouveau 2028",aimed at becoming the best of brands in convenience retailing.Growth drivers based onthree key market segments : Being the go-to choice for day-to-day food shopping;Becoming a major player in Quick Meal Solutions;Being the leader in providing new everyday services.To kickstart this transformation, we will be...
Nasdaq GlobeNewswire
14/11/2024
Altri  Comunicati